BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 12765608)

  • 1. Cdk5 is a key factor in tau aggregation and tangle formation in vivo.
    Noble W; Olm V; Takata K; Casey E; Mary O; Meyerson J; Gaynor K; LaFrancois J; Wang L; Kondo T; Davies P; Burns M; Veeranna ; Nixon R; Dickson D; Matsuoka Y; Ahlijanian M; Lau LF; Duff K
    Neuron; 2003 May; 38(4):555-65. PubMed ID: 12765608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.
    Bian F; Nath R; Sobocinski G; Booher RN; Lipinski WJ; Callahan MJ; Pack A; Wang KK; Walker LC
    J Comp Neurol; 2002 May; 446(3):257-66. PubMed ID: 11932941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
    Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice.
    Götz J; Nitsch RM
    Neuroreport; 2001 Jul; 12(9):2007-16. PubMed ID: 11435938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
    Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain.
    Takashima A; Murayama M; Yasutake K; Takahashi H; Yokoyama M; Ishiguro K
    Neurosci Lett; 2001 Jun; 306(1-2):37-40. PubMed ID: 11403952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles.
    Augustinack JC; Sanders JL; Tsai LH; Hyman BT
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):557-64. PubMed ID: 12071639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.
    Ahlijanian MK; Barrezueta NX; Williams RD; Jakowski A; Kowsz KP; McCarthy S; Coskran T; Carlo A; Seymour PA; Burkhardt JE; Nelson RB; McNeish JD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2910-5. PubMed ID: 10706614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
    Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.